本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

拜玛林制药

56.65
+1.382.50%
盘前57.100.4500+0.79%04:25 EDT
成交量:212.51万
成交额:1.20亿
市值:108.64亿
市盈率:20.94
高:57.81
开:55.64
低:55.64
收:55.27
数据加载中...
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/22

重要事件披露

Form 8-K - Current report
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/10

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]